Skip to content
BIO 2025: How weight loss drugs are disrupting chronic disease
“Initial weight loss is just the first chapter,” said Mia de Graaf, Deputy ...
Read More
BIO 2025: Psychedelics go mainstream – what’s next?
When experts discussed clinical uses of psychedelics two years ago at the 2023 ...
Read More
Mother inspired to support solutions for her boys’ blindness
For most of her life, the only things coming out of left field ...
Read More
BIO experts discuss challenges and offer opportunities for developing redosable gene therapies
As drug makers work to develop safe, effective gene therapies, their progress can ...
Read More
BIO 2025: Federal seed funding also comes with valuable advice
The federal government’s program that provides seed funding to support research by biotech ...
Read More
BIO 2025: Legal experts break down cases against IRA price controls
Litigation opposing drug price controls in the Inflation Reduction Act (IRA) has yet ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
BIO Events
BIO 2025: How weight loss drugs are disrupting chronic disease
“Initial weight loss is just the first chapter,” said Mia de Graaf, Deputy Executive Health Editor at Business Insider, “but the real challenge and opportunity ...
BIO Events
BIO 2025: Psychedelics go mainstream – what’s next?
When experts discussed clinical uses of psychedelics two years ago at the 2023 Biotechnology Innovation Organization (BIO) International Convention, there was some interest in separating ...
Health
Mother inspired to support solutions for her boys’ blindness
For most of her life, the only things coming out of left field for Kristin Smedley were fly balls, but with the birth of her ...
Federal Policy
BIO experts discuss challenges and offer opportunities for developing redosable gene therapies
As drug makers work to develop safe, effective gene therapies, their progress can be slowed when they challenge the limits of established regulatory guidance on ...
Federal Policy
BIO 2025: Federal seed funding also comes with valuable advice
The federal government’s program that provides seed funding to support research by biotech startups provides much more than money, said program officials and small biotechs ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Life sciences job report shows growth slowing, but firms still invest in talent
As the United States has long been a life sciences leader, the health of the life sciences sector is a ...
Read More
International
Bio's View
Emerging biotechs get bearish to weather market trends, finds BIO report
“Small companies are the lifeblood of the industry and a lot of what they do, and what they’re experiencing, greatly ...
Read More
